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PURPOSE: To correlate perilesional enhancement on gadolinium-enhanced mag-
netic resonance (MR) images with histopathologic findings in patients with hepatic
metastases.
MATERIALS AND METHODS: In seven patients with histopathologically proved
hepatic metastases, MR images obtained before and early and late after the
administration of gadopentetate dimeglumine were retrospectively evaluated for
perilesional enhancement. The thickness of hepatic parenchyma with intense
perilesional enhancement was calculated. The thickness of the histologic tumor
border (the zone separating the outermost border of the tumor nodule from the
surrounding hepatic parenchyma) also was measured.
RESULTS: In three patients, early gadolinium-enhanced images showed prominent
perilesional enhancement, which correlated with a thick tumor border containing
peritumoral desmoplastic reaction, peritumoral inflammation, and vascular prolifera-
tion at histopathologic examination. In one patient, mild perilesional enhancement
was shown. At histopathologic examination, the lesion periphery showed moderate
peritumoral changes. In the remaining three patients, no perilesional enhancement
was observed, and at histopathologic examination there was a thin tumor border
that contained minimal to mild perilesional changes. The thickness of hepatic
parenchyma with intense perilesional enhancement on early gadolinium-enhanced
images showed a strong positive correlation with tumor border thickness at
histopathologic examination (r 5 0.99).
CONCLUSION: Intense perilesional enhancement of metastases on early gadolinium-
enhanced MR images correlates with histopathologic hepatic parenchymal changes,
which include peritumoral desmoplastic reaction, inflammatory cell infiltration, and
vascular proliferation.
Intense perilesional enhancement on dynamic contrast material–enhanced computed
tomographic (CT) images and on magnetic resonance (MR) images acquired immediately
after the administration of contrast material has been observed for a number of hepatic
metastases and results in indistinct outer tumor margins and overestimation of tumor size
(1,2).
Because dynamic gadolinium-enhanced MR imaging is used routinely for the evaluation
and follow-up of focal hepatic lesions in many centers, the recognition and understanding
of transient perilesional enhancement and its distinction from true lesional enhancement
may be important for several reasons. Transient perilesional enhancement with subsequent
washout on contrast-enhanced images may help to distinguish malignant from benign
hepatic lesions. The determination of the exact size and location of a metastasis may be
important for the planning of surgery; for the planning of minimally invasive therapy,
such as cryoablation; and for the planning and follow-up of systemic chemotherapy.
To our knowledge, previous to our study, few studies have addressed the occurrence and
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possible causes of perilesional enhance-
ment on postcontrast CT and MR images
(1–4). The majority of these studies (2–4)
did not have histologic correlation, and
the investigators in these studies postu-
lated that the perilesional enhancement
reflects the complex relationship be-
tween the dual blood supply of the liver
and the local hepatic parenchymal and
perfusional changes or simply correlated
the findings with angiographic findings
(3).
Authors of a recent study (1) correlated
CT arterial portographic and equilibrium-
phase postcontrast CT findings directly
with histopathologic findings in 13 hepato-
cellular carcinomas and six hepatic metas-
tases and described various factors that
caused an overestimation of tumor size
on images acquired at CT during arterial
portography. To our knowledge, perilesional
enhancement on dynamic, gadolinium-
enhanced MR images in patients with
hepatic metastases has not been corre-
lated previously with histopathologic
findings of the tumor border, which is
defined as the zone separating the outer-
most margin of the tumor nodule from
the surrounding hepatic parenchyma.
The purpose of this study was to deter-
mine the correlation of perilesional en-
hancement on gadolinium-enhanced MR
images with histopathologic findings in
patients with hepatic metastases.
MATERIALS AND METHODS
The clinical records of all patients with
hepatic metastases who underwent MR
imaging between August 1994 and Au-
gust 1998 were cross-referenced with his-
topathology records in our center (the
University of North Carolina Hospital).
The patients were referred for an MR
imaging study as their initial examina-
tion of the hepatobiliary system or as the
follow-up examination of focal hepatic
lesions shown on prior images.
Patients were included in the study if
they met the following criteria: (a) having
undergone resection of the hepatic metasta-
sis and the surrounding hepatic paren-
chyma, (b) having undergone both MR
imaging and surgery within 1 month, and
(c) having undergone no intervening thera-
peutic intervention, including chemother-
apy, between MR imaging and histopatho-
logic examination. The clinical records of
all patients were checked for evidence of
chemotherapy or other treatments.
Fourteen patients met these entrance
criteria; however, only seven patients had
sufficient material to evaluate the tumor
border well at histopathologic examina-
tion and met the inclusion criteria of our
study. There were four men and three
women, with an age range of 41–71 years
(mean age, 56.1 years).
The hepatic metastases originated from
the following primary tumors: colorectal
carcinoma (n 5 5), neuroendocrine tu-
mor of the pancreas (n 5 1), and transi-
tional cell carcinoma of the bladder (n 5
1). In one of the five patients with metas-
tasis from colorectal carcinoma, histo-
pathologic findings were consistent with
mucinous adenocarcinoma, whereas the
remaining four patients had nonmuci-
nous adenocarcinoma.
In three patients, including two with
colorectal hepatic metastases and one
with metastases from neuroendocrine tu-
mor of the pancreas, the metastatic le-
sions were multiple. In these patients, all
lesions were nearly identical in appear-
ance, and in each of these three patients
only one lesion, the largest, was mea-
sured. The remaining four patients had
solitary metastases.
MR imaging was performed with a 1.5-T
MR imager (Vision; Siemens Medical Sys-
tems, Iselin, NJ). MR imaging included a
T1-weighted, in-phase, breath-hold, spoiled
gradient-echo sequence (repetition time
of 140–175 msec and echo time of 4.1–4.5
msec [140–175/4.1–4.5]; flip angle, 80°;
section thickness, 8 mm; intersection gap,
20%; one signal acquired; 21 sections in a
20-second breath hold).
Transverse spoiled gradient-echo images
were acquired just prior to and immedi-
ately after intravenous bolus injection of
0.1 mmol per kilogram of body weight
gadopentetate dimeglumine (Magnevist;
Berlex Laboratories, Wayne, NJ), at 45
seconds, at 90 seconds with fat suppres-
sion, and at 5–10 minutes. From these five
sets of images, the precontrast images, the
immediately postcontrast (early) images,
and the 5–10 minutes postcontrast (late)
images were reviewed to determine the
lesion diameter, and perilesional enhance-
ment was determined on early postcon-
trast images.
One reader (S.M.H.), who was blinded
to the histopathologic information and
to the original MR imaging reports, retro-
spectively evaluated the transverse pre-
contrast and early and late dynamic gado-
linium-enhanced MR images in each
patient. The retrospective MR imaging
data were compared with the original MR
imaging reports to determine the level of
agreement for the identification of en-
hancement features of the metastatic le-
sions and of the hepatic parenchyma that
surrounded the metastases.
The following features were evaluated:
(a) intense perilesional enhancement;
(b) the pattern of perilesional enhance-
ment, characterized as wedge-shaped sub-
segmental or as circumferential perilesional
enhancement; (c) the intensity of peri-
lesional enhancement, as evaluated in a
semiquantitative fashion with 111 mean-
ing that perilesional enhancement was
prominent, 11 meaning that it was mod-
erate, 1 meaning that it was mild, -1 mean-
ing that it was minimal, and - meaning
that it was not seen; and (d) the longest
transverse tumor diameter (in millime-
ters) on precontrast, early postcontrast,
and late postcontrast images.
The thickness of hepatic parenchyma
with intense perilesional enhancement
was determined as follows: (DPM 2 DMPre 5
THP), where D is diameter, PM is enhanc-
ing perilesional tissue and metastasis,
MPre is metastasis on precontrast images,
and THP is the thickness of the part of the
hepatic parenchyma with intense perile-
sional enhancement. Measurements were
made on the same lesion with histologic
proof, which was usually the largest le-
sion. Images were randomly sorted, and
measurements were performed by using
mechanical calipers.
The original hepatic biopsy or resec-
tion specimens were evaluated by an expe-
rienced hepatic pathologist (J.T.W.), who
was blinded to the MR imaging findings.
The histopathologic evaluation included
the following: (a) evaluation of the metas-
tasis, which included the histologic type,
histologic differentiation, and the pres-
ence of fibrous stroma; (b) evaluation of
the tumor border that surrounded the
metastasis, which included peritumoral
desmoplastic reaction, compressed he-
patic parenchyma, atrophy of the hepatic
cords, lymphocytic infiltration reflecting
inflammation, vascular proliferation, in-
direct evidence of shunting such as the
absence of fatty infiltration adjacent to
the tumor in a predominantly fatty liver,
vasculitis, and portal venous obstruction
by tumor emboli; and (c) measurement of
the tumor border in millimeters.
Histopathologic evaluation of the ex-
tent of the perilesional changes was per-
formed in a semiquantitative fashion by
using the following scale: A rating of
111 indicated prominent perilesional
changes; 11, moderate; 1, mild; 21,
minimal; and 2, none seen.
The Pearson correlation coefficient was
calculated to compare the thickness of
the intense perilesional enhancement on
early gadolinium-enhanced images and
the tumor border at histopathologic ex-
amination.
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RESULTS
Exact agreement was observed between
the retrospective and prospective read-
ings of the extent of perilesional enhance-
ment on immediately postcontrast im-
ages. In three of the seven patients, the
lesions showed prominent perilesional
enhancement, with indistinct outer tumor
margins on early gadolinium-enhanced
spoiled gradient-echo images (Fig 1). Ap-
proximately 20% of lesions had perile-
sional enhancement changes that were
wedge-shaped. On late gadolinium-en-
hanced images, the perilesional enhance-
ment diminished markedly or disap-
peared.
Athistopathologic examination, the three
patients’ lesions were moderately differen-
tiated adenocarcinomas, consistent with
a colorectal primary carcinoma, with promi-
nent to moderate fibrotic tumor stroma.
The tumor border of these lesions showed
moderate to prominent peritumoral des-
moplastic reaction, mild to prominent
peritumoral inflammation, minimal to
mild vascular proliferation, and mild in-
flammatory cell infiltration (Fig 1). Com-
pression of hepatic parenchyma and atro-
phy of the hepatic cords were not prominent
features in these lesions.
In one of these three patients, there
was minimal absence of fatty infiltration
adjacent to the tumor, which may be con-
sidered an indirect sign of shunting of
portal blood. No evidence was found of
vasculitis or portal venous obstruction (tu-
mor emboli) at histopathologic examina-
tion of the three patients’ lesions with
prominent peritumoral changes.
In one of the seven patients, early
gadolinium-enhanced spoiled gradient-
echo images showed mild perilesional
enhancement and indistinct outer tumor
margins. Associated wedge-shaped vascu-
lar abnormalities were not present. On
late postcontrast images, the perilesional
enhancement disappeared. At histopatho-
logic examination, the lesion was moder-
ately differentiated mucinous adenocarci-
noma, consistent with a colorectal primary
carcinoma, with prominent fibrotic tu-
mor stroma. The tumor border showed
moderate peritumoral desmoplastic reac-
tion, mild compression of the surround-
ing hepatic parenchyma, mild atrophy of
the hepatic cords, minimal inflammatory
cells, and minimal vascular proliferation.
In the remaining three patients, no
perilesional enhancement was observed
on the early gadolinium-enhanced MR
images (Fig 2). No wedge-shaped vascular
abnormalities were present. At histopatho-
logic examination, minimal tumor border
changes were seen, which included mini-
mal peritumoral desmoplastic reaction,
minimal compression of hepatic paren-
chyma, minimal or mild atrophy of the
hepatic cords, mild peritumoral inflam-
mation, and minimal vascular prolifera-
tion. Table 1 contains comprehensive data
and compares perilesional enhancement
on MR images and histopathologic find-
ings.
The thickness of hepatic parenchyma
with intense perilesional enhancement
on early gadolinium-enhanced images
showed a strong positive correlation with
the increasing thickness and the increas-
ing cellular changes of the tumor border
at histopathologic examination (r 5 0.99)
(Table 2). The hepatic parenchyma with
perilesional enhancement on early gado-
linium-enhanced images was systemati-
cally thicker than the histologic tumor
a. b.
Figure 1. Patient 2. Prominent perilesional enhancement. (a) Transverse, immediately postcon-
trast, spoiled gradient-echo (150/4.1, 80° flip angle) MR image shows intense perilesional
enhancement (arrow). (b) Photomicrograph of the histologic specimen demonstrates prominent
peritumoral desmoplastic reaction, prominent peritumoral inflammatory cell infiltration (short
arrow), mild vascular proliferation (long arrow), mildly compressed hepatic parenchyma, and
minimal atrophy of the hepatic cords. The nodule of metastatic, moderately differentiated
adenocarcinoma (T) is separated from the hepatic parenchyma (L) by a 0.5-mm-thick zone
(dashed line) of fibrocellular stroma (S). (Hematoxylin-eosin stain; original magnification, 3100.)
a. b. c.
Figure 2. Patient 5. No perilesional enhancement. (a) Transverse, precontrast, spoiled gradient-echo (150/4.1, 80° flip angle) MR image
demonstrates a large metastasis in the right lobe of the liver. (b) Transverse, immediately postcontrast, spoiled gradient-echo (150/4.1, 80° flip angle)
MR image shows no perilesional enhancement and a sharp, external border to the metastasis (arrow). The lesion diameter is identical to that in a.
(c) Photomicrograph of the histologic specimen demonstrates no peritumoral desmoplastic reaction, mild peritumoral inflammatory cell
infiltration, minimal vascular proliferation, minimally compressed hepatic parenchyma, and minimal atrophy of the hepatic cords. The nodule of
metastatic, moderately differentiated adenocarcinoma (T) is separated from the surrounding hepatic parenchyma (L) by a 0.1-mm-thick zone
(dashed line) of fibrocellular stroma (S). (Hematoxylin-eosin stain; original magnification, 3100.)
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border in all patients. The increased en-
hancement on MR images was therefore
not confined to the tumor border. The
size of the lesions was unrelated to the
extent of perilesional changes at histo-
pathologic examination (r 5 0.10).
In two of the seven patients with colo-
rectal metastases (Table 1, patients 3 and
5), systemic chemotherapy was adminis-
tered prior to MR imaging (but not be-
tween MR imaging and histologic assess-
ment), which may have contributed to
variable findings at MR imaging and at
histopathologic examination. In one of
these two patients, a decrease in perile-




Results of previous studies (2) in which
immediately postcontrast images were
used have shown perilesional enhance-
ment that surrounded certain metastases.
The hepatic metastases most commonly
associated with this appearance have been
from colorectal carcinomas (2). In our
study, all patients with intense perile-
sional enhancement had colon cancer.
Authors of prior studies that employed
CT examinations correlated the peritu-
moral hepatic parenchymal changes in
hepatocellular carcinomas and in hepatic
metastases with histopathologic findings
(1,5). By using a microvascular injection
technique, Lin et al (5) demonstrated
compressed hepatic sinusoids that formed
an avascular zone in the liver adjacent to
four of 15 metastases.
More recently, Kanematsu et al (1) as-
sessed the overestimation of the size of
the hepatic malignancy at CT during
arterial portography and compared the
findings to the findings of equilibrium-
phase CT and histopathologic examina-
tion. In that study, the CT findings of 19
resected tumors in 16 patients (13 pa-
tients with hepatocellular carcinomas and
three with hepatic metastases) were di-
rectly compared with histopathologic
findings (1). At histopathologic examina-
tion, the perilesional enhancement cor-
related with flattening of parenchymal
structures, sinusoidal congestion, fibro-
sis, and ductular proliferation (1). Similar
to the histopathologic examination in
that study, the histopathologic examina-
tion in our patients with intense perile-
sional enhancement on early gadolinium-
enhanced images showed a close correlation
with peritumoral desmoplastic reaction,
with peritumoral inflammatory cell infil-
trates such as eosinophils and lympho-
cytes, and with vascular proliferation.
Investigators in previous MR imaging
studies correlated the findings of T1- and
T2-weighted MR imaging and histopatho-
logic parenchymal changes in the periph-
ery of hepatocellular carcinomas and colo-
rectal hepatic metastases (6,7). According
TABLE 1




















1 111 111 2 21 111 1
2 111 111 1 21 111 1
3 111 11 21 21 1 21
4 1 11 1 1 21 21
5 2 2 21 1 1 21
6 2 21 21 21 2 2
7 2 2 2 2 2 2
Note.—111 5 Prominent, 11 5 moderate, 1 5 mild, 21 5 minimal, 2 5 none. Patients 1–5 had metastases from colorectal carcinomas, including a
mucinous type (patient 4); patient 6 had a metastasis from a transitional cell carcinoma; and patient 7 had a metastasis from a neuroendocrine pancreatic
tumor.
TABLE 2
Long-Axis Tumor Diameter on MR Images
Patient
No.


















1 35 48 36 13 1 0.6
2 51 62 52 11 1 0.5
3 50 60 48 10 22 0.5
4 41 44 42 3 1 0.2
5 119 121 120 2 1 0.1
6 38 39 38 1 0 0.1
7 11 11 11 0 0 0
Note.—The larger the difference in tumor diameters on early postcontrast and precontrast images, the greater the perilesional enhancement. The
differences in tumor diameters on early postcontrast and precontrast images showed a high correlation with the tumor border measurements (r 5 0.99).
Patients 1–5 had metastases from colorectal carcinomas, including a mucinous type (patient 4); patient 6 had a metastasis from a transitional cell
carcinoma; and patient 7 had a metastasis from a neuroendocrine pancreatic tumor.
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to Itoh et al (6), the inner low-signal-
intensity band encompassing hepato-
cellular carcinomas on T2-weighted spin-
echo images corresponds to the fibrous
capsules, and the outer relatively high-
signal-intensity area is histopathologi-
cally consistent with compressed vessels
or bile duct proliferation.
Outwater et al (7) studied the morpho-
logic patterns of colorectal hepatic metas-
tases on T1- and T2-weighted spin-echo
images in 76 patients. In 33 patients with
36 nodules, there was sufficient biopsy or
resection material to yield a direct correla-
tion between the MR imaging findings
and histopathologic findings at the tu-
mor edge and hepatic border. At histo-
pathologic examination, 12 of 33 patients
with low-signal-intensity rims around tu-
mor nodules on the T2-weighted images
showed histopathologic changes in the
hepatic parenchyma adjacent to the tu-
mor (7). The most frequent histopatho-
logic changes included compression of
hepatic parenchyma, hepatocellular atro-
phy, fibrosis, inflammation, and con-
gested sinusoids (7).
The findings of the tumor border in our
study confirmed the results of previous
studies (1,5,6). In our study, although com-
pressed hepatic parenchyma and atrophy
of the hepatic cords were present in a
majority of cases (Table 1), a combination
of peritumoral desmoplastic reaction,
peritumoral inflammatory cell infiltrates
such as eosinophils and lymphocytes, and
vascular proliferation correlated best with
perilesional enhancement. Correlation be-
tween the extent of perilesional enhance-
ment and the thickness of the tumor
border was excellent; however, the thick-
ness of the area with increased enhance-
ment on MR images was systematically
greater. Therefore, the increased perile-
sional enhancement was not confined to
the histologic tumor border. Explanation
for this difference likely includes shrink-
age of the histopathologic specimen and
enhancement on MR images that extends
beyond the tumor border into the sur-
rounding liver.
We presume that the inflammatory in-
filtrate in the tumor border increases per-
fusion in the adjacent zone of surround-
ing hepatic parenchyma by releasing local
factors. The close correlation between the
extent of peritumoral desmoplastic reac-
tion and peritumoral inflammation in
four of the five patients with colorectal
hepatic metastases suggests that these
findings may be interrelated and may
result from the inherent histopathologic
features of these metastases. Correlation
between the perilesional hepatic paren-
chymal changes and the tumor grade,
extent of differentiation of metastases, or
their histologic type, such as mucinous or
nonmucinous, would have been interest-
ing to evaluate; however, the number
of patients in our study was too small for
stratification into different categories. Mini-
mal to mild compressed hepatic paren-
chyma and atrophy of the hepatic cords
in the majority of patients in our study
may have been related to mechanical
factors that resulted from tumor growth.
Several mechanisms have been pro-
posed to explain the local increase in he-
patic perfusion (3,4,8–10). These mecha-
nisms include increased hepatic arterial
flow caused by arterialization of a zone
deprived of portal venous flow secondary
to tumor occlusion; increased hepatic ar-
terial flow caused by a siphoning effect of
a hypervascular tumor and tumor vessels;
and compressed hepatic parenchyma
caused by a large intrahepatic mass, which
produces an area of hypervascularity.
In addition, on the basis of our data,
the increased number of inflammatory
cells in the tumor border likely induces
an inflammatory response in adjacent
hepatic parenchyma. A combination of
these mechanisms may have been respon-
sible for the perilesional enhancement
and for the wedge-shaped regions of in-
creased enhancement observed in some
of the patients in our study. It is pre-
sumed that hepatocellular damage in-
duced by the presence of the tumor or by
excretion of tumor metabolites in the
direct vicinity of the tumor may have
provoked inflammation and tumor neo-
vascularity, which also may have contrib-
uted to the perilesional enhancement seen
on early gadolinium-enhanced MR im-
ages.
Two patients in this study with colo-
rectal hepatic metastases and with vari-
able degrees of perilesional enhancement
received systemic chemotherapy. In one
of these two patients, MR imaging was
performed prior to and after the initia-
tion of chemotherapy and showed an
interval decrease in perilesional changes.
In the second patient, however, no MR
imaging was performed prior to chemo-
therapy; therefore, the effect of chemo-
a. b.
c. d.
Figure 3. Patient 3. Serial changes in perilesional enhancement after systemic chemotherapy.
(a, b) Prechemotherapy, transverse, (a) precontrast and (b) early postcontrast and (c) postchemo-
therapy, early postcontrast, spoiled gradient-echo (150/4.1, 80° flip angle) MR images. Intense
perilesional enhancement (arrow in b) is appreciated in b and results in a considerable increase in
lesion diameter from a to b. In c, after the initiation of chemotherapy, a mild decrease in intense
perilesional enhancement is appreciated. (d) Photomicrograph of the postchemotherapy histo-
logic specimen demonstrates moderate peritumoral desmoplastic reaction, mild peritumoral
inflammatory cell infiltration (short arrow), minimal vascular proliferation (long arrow), mini-
mally compressed hepatic parenchyma, and minimal atrophy of the hepatic cords. The nodule of
metastatic, moderately differentiated adenocarcinoma (T) is separated from the hepatic paren-
chyma (L) by a 0.5-mm-thick zone (dashed line) of fibrocellular stroma (S). (Hematoxylin-eosin
stain; original magnification, 3100.)
Volume 215 • Number 1 Perilesional Enhancement of Hepatic Metastases: MR Imaging–Histopathology • 93
therapy could not be assessed. Chemo-
therapeutic agents reduce the tumor
growth rate, inflammatory changes, and
tumor angiogenesis (11), all of which
may contribute to a decrease in perile-
sional enhancement. A decrease in peritu-
moral enhancement during chemother-
apy, as observed in one of our patients, to
our knowledge has not been described
previously.
We believe that one of the most impor-
tant features of the observation of the
thickness and intensity of both the perile-
sional enhancement and the enhance-
ment of the outer layer of the tumors
themselves is that they may reflect a
response to therapeutic interventions
such as systemic chemotherapy. That is
why we routinely describe these features
in our prospective MR imaging reports, as
was done for the patients in this study.
Nonetheless, more investigative work
needs to be performed to understand the
frequency of the enhancement and its
relation to histopathologic findings of
metastatic disease and tumor growth rates.
Also of great interest is the determination
of whether tumor metabolites are in part
responsible for the histopathologic changes.
Our study had several limitations: the
small number of patients, which reflected
the requirements for hepatic histopatho-
logic examination performed relatively
concurrently with MR imaging; the need
for peritumoral hepatic parenchyma in
the histopathologic specimen; the lack of
intervening therapy between MR imag-
ing and surgery; and the single-institu-
tional nature of our study.
On the basis of the small number of
patients, the results should be considered
initial observations that require a larger
number of patients to be validated. The
discrepancy between MR imaging and
histopathologic findings in some of our
patients may in part have been attribut-
able to variability in histopathologic sam-
pling. Our hospital (the University of
North Carolina Hospital) is a tertiary refer-
ral center for body MR imaging, and many
patients who were referred for MR imaging
underwent histopathologic work-up else-
where. Often, the histopathologic mate-
rial from such patients is inaccessible.
Currently, cross-sectional imaging mo-
dalities, including CT and MR imaging,
allow the diagnosis of hepatic metastases
noninvasively. In many cases, patients
undergo fine-needle aspiration biopsy to
confirm the imaging findings. Finally,
because of the introduction of systemic
chemotherapy and the various mini-
mally invasive surgical techniques, which
include cryotherapy, alcohol injection,
and thermal ablation, in many patients
with hepatic metastases, surgical resec-
tion may not be the first choice of treat-
ment.
In conclusion, transient perilesional en-
hancement surrounding hepatic metasta-
ses on early gadolinium-enhanced MR
images correlates with the increased thick-
ness of the histologic tumor border and
with histopathologic hepatic parenchy-
mal changes, which include peritumoral
desmoplastic reaction, inflammatory cell
infiltration, and vascular proliferation.
References
1. Kanematsu M, Hoshi H, Yamada T, et al.
Overestimating the size of hepatic malig-
nancy on helical CT during arterial portogra-
phy: equilibrium phase CT and pathol-
ogy. J Comput Assist Tomogr 1997; 21:
713–719.
2. Larson RE, Semelka RC, Bagley AS, Molina
PL, Brown ED, Lee JKT. Hypervascular malig-
nant liver lesions: comparison of various
MR imaging pulse sequences and dy-
namic CT. Radiology 1994; 192:393–399.
3. Freeny PC, Marks WM. Hepatic perfusion
abnormalities during CT angiography: de-
tection and interpretation. Radiology
1986; 159:685–691.
4. Itai Y, Moss AA, Goldberg HI. Transient
hepatic attenuation difference of lobar or
segmental distribution detected by dy-
namic computed tomography. Radiology
1982; 144:835–839.
5. Lin G, Gustafson T, Hagerstrand I, Lunder-
quist A. CT demonstration of low density
ring in liver metastasis. J Comput Assist
Tomogr 1984; 8:450–452.
6. Itoh K, Nishimura K, Togashi K, et al.
Hepatocellular carcinoma: MR imaging.
Radiology 1987; 164:21–25.
7. Outwater E, Tomaszewski JE, Daly JM,
Kressel HY. Hepatic colorectal metastases:
correlation of MR imaging and pathologic
appearance. Radiology 1991; 180:327–
332.
8. Bookstein JJ, Cho KJ, Davis GB, Dail D.
Arterioportal communications: observa-
tions and hypotheses concerning trans-
sinusoidal and transvasal types. Radiol-
ogy 1982; 142:581–590.
9. Heeney DJ, Bookstein JJ, Bell RH, Orloff
MJ, Miyai K. Correlation of hepatic and
portal wedge venography and manometry
with histology in alcoholic cirrhosis and
periportal fibrosis. Radiology 1982; 142:
591–597.
10. Matsui O, Takashima T, Kadoya M, et al.
Segmental staining on hepatic arteriogra-
phy as a sign of intrahepatic portal vein
obstruction. Radiology 1982; 152:601–
606.
11. Arisawa Y, Sutanto-Ward E, Fortunato L,
Sigurdson ER. Hepatic artery dexametha-
sone infusion inhibits colorectal hepatic
metastases: a regional antiangiogenesis
therapy. Ann Surg Oncol 1995; 2:114–120.
94 • Radiology • April 2000 Semelka et al
